SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-161167
Filing Date
2021-05-14
Accepted
2021-05-14 06:14:02
Documents
81
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d543481d10ka.htm 10-K/A 1037032
2 EX-23.1 d543481dex231.htm EX-23.1 1273
3 EX-31.1 d543481dex311.htm EX-31.1 6774
4 EX-31.2 d543481dex312.htm EX-31.2 6765
5 EX-32.1 d543481dex321.htm EX-32.1 3308
6 EX-32.2 d543481dex322.htm EX-32.2 3319
13 GRAPHIC g543481g12c55.jpg GRAPHIC 131445
14 GRAPHIC g543481g14c12.jpg GRAPHIC 80736
15 GRAPHIC g543481g15l30.jpg GRAPHIC 86134
16 GRAPHIC g543481g16a01.jpg GRAPHIC 128602
17 GRAPHIC g543481g16a02.jpg GRAPHIC 126486
18 GRAPHIC g543481g17q10.jpg GRAPHIC 146936
19 GRAPHIC g543481g18a05.jpg GRAPHIC 143277
20 GRAPHIC g543481g18a06.jpg GRAPHIC 144453
21 GRAPHIC g543481g20x33.jpg GRAPHIC 169701
22 GRAPHIC g543481g50y63.jpg GRAPHIC 97527
  Complete submission text file 0001193125-21-161167.txt   6463055

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT lsacu-20201231.xml EX-101.INS 796781
8 XBRL TAXONOMY EXTENSION SCHEMA lsacu-20201231.xsd EX-101.SCH 46547
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE lsacu-20201231_cal.xml EX-101.CAL 33480
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE lsacu-20201231_def.xml EX-101.DEF 218224
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE lsacu-20201231_lab.xml EX-101.LAB 383168
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE lsacu-20201231_pre.xml EX-101.PRE 318729
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39244 | Film No.: 21921829
SIC: 2834 Pharmaceutical Preparations